← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 1, 2001Last known activity
Sep 1, 2020
Timeline
1990s
- Jun 1, 1997
Italian Sarcoma Group— Founded
Drugs by trial phase (26 distinct, 23 trials)
Phase 3 (16 own, 0 via acquisition)
Phase 2 (9 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Indications
Recent trials (30)
- NCT04383119Lead sponsorPhase 2Sep 1, 2020
- NCT04305548Lead sponsorPhase 2Sep 1, 2020
- NCT04274023Lead sponsorPhase 2May 1, 2020
- NCT03782363Lead sponsorPhase 1Mar 1, 2020
- NCT03838744Lead sponsorPhase 2Aug 31, 2019
- NCT03840772Lead sponsorPhase 2Jun 30, 2019
- NCT03773510Lead sponsorPhase 3Feb 28, 2019
- NCT03013127CollaboratorPhase 2May 30, 2017
- NCT03023124Lead sponsorPhase 2Mar 1, 2017
- NCT03023124Overall official - principal investigatorPhase 2Mar 1, 2017
- NCT02718482Lead sponsorPhase 2Apr 1, 2016
- NCT02275286CollaboratorPhase 1/Phase 2Nov 1, 2014
- NCT02398058Overall official - principal investigatorPhase 1Oct 1, 2014
- NCT02398058Lead sponsorPhase 1Oct 1, 2014
- NCT02247544Lead sponsorPhase 2Mar 1, 2014
Details
- Founded
- San Lazzaro di Savena, IT Jun 1, 1997
- Last known activity
- Sep 1, 2020